
Suspicious Kalshi Bets Predicted Trump’s Press Secretary Pick Before Announcement
By JOSEPH CURL
|The National Health Service said Friday that ‘outside of a research setting, puberty suppressing hormones should not be routinely commissioned for children and adolescents.’

LONDON — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms.

By JOSEPH CURL
|
By CARL ROLLYSON
|
By THE NEW YORK SUN
|
By CONRAD BLACK
|
By A.R. HOFFMAN
|
By BRADLEY CORTRIGHT
|
By DAVID HARSANYI
|
By LUKE FUNK
|LONDON — The publicly funded health service in England has decided it will not routinely offer puberty-blocking drugs to children at gender identity clinics, saying more evidence is needed about the potential benefits and harms.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.
Cancel anytime